Is Adjuvant Immunotherapy Worth for All Patients with Clear-cell Renal Cell Carcinoma at High Risk of Recurrence?

oleh: Michele Marchioni, Daniele Amparore, Laura Marandino, Riccardo Bertolo, Selcuk Erdem, Alexandre Ingels, Stijn Muselaers, Onder Kara, Nicola Pavan, Eduard Roussel, Umberto Carbonara, Angela Pecoraro, Pietro Diana, Alessio Pecoraro, Riccardo Campi

Format: Article
Diterbitkan: Elsevier 2022-12-01

Deskripsi

No description available for this item.